Ultrasensitive Detection of FEN1 Activity for Cancer Diagnosis Using a CRISPR/Cas13a‐Based Triple Cascade Amplification System
Authors:
- 29 December 2024
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (6) , e2404411
Abstract
Flap endonuclease 1 (FEN1) is closely associated with tumor progression and proliferation, making it a promising biomarker for cancer diagnosis. However, developing a sensitive, reliable, and user‐friendly method for quantitative FEN1 detection remains technically challenging. In this study, an ultrasensitive FEN1 biosensor is established using a target‐induced cleavage‐ligation‐transcription‐activation cascade strategy (LTACas13a) to enhance the cleavage ability of CRISPR/Cas13a. The LTACas13a method has shown excellent performance in screening FEN1 inhibitors and detecting endogenous FEN1 activity in living cells, as well as in clinical biological samples such as human serum and tissue samples. Additionally, using a universal dumbbell probe derived from FEN1, a multiplex LTACas13a strategy is developed for detecting various DNA glycosylases, including formamidopyrimidine DNA glycosylase, uracil DNA glycosylase, and human alkyl adenine DNA glycosylase. This straightforward approach provides a reliable and effective diagnostic tool for early‐stage cancer detection and offers significant opportunities for FEN1 biosensing and related drug discovery.Keywords
Funding Information
- National Natural Science Foundation of China (22104090, 82102184, 82204349, 82170526, 62305207)
This publication has 45 references indexed in Scilit:
- Photoactivatable Engineering of CRISPR/Cas9‐Inducible DNAzyme Probe for In Situ Imaging of Nuclear Zinc IonsAngewandte Chemie International Edition, 2024
- CRISPR/Cas13a‐Based MicroRNA Detection in Tumor‐Derived Extracellular VesiclesAdvanced Science, 2023
- A Simplified Amplification‐Free Strategy with Lyophilized CRISPR‐CcrRNA System for Drug‐Resistant Salmonella DetectionSmall, 2023
- Programmable CRISPR-Cas12a and self-recruiting crRNA assisted dual biosensing platform for simultaneous detection of lung cancer biomarkers hOGG1 and FEN1Analytica Chimica Acta, 2022
- Fluorometric detection of cancer marker FEN1 based on double-flapped dumbbell DNA nanoprobe functionalized with silver nanoclustersAnalytica Chimica Acta, 2021
- Contamination-free visual detection of SARS-CoV-2 with CRISPR/Cas12a: A promising method in the point-of-care detectionBiosensors and Bioelectronics, 2020
- End-point dual specific detection of nucleic acids using CRISPR/Cas12a based portable biosensorBiosensors and Bioelectronics, 2020
- Contamination-free visual detection of CaMV35S promoter amplicon using CRISPR/Cas12a coupled with a designed reaction vessel: Rapid, specific and sensitiveAnalytica Chimica Acta, 2020
- CRISPR/Cas13a‐Powered Electrochemical Microfluidic Biosensor for Nucleic Acid Amplification‐Free miRNA DiagnosticsAdvanced Materials, 2019
- Overexpression of Flap Endonuclease 1 Correlates with Enhanced Proliferation and Poor Prognosis of Non–Small-Cell Lung CancerThe American Journal of Pathology, 2018